Annual EBITDA
$851.39M$34.59M+4.23%
Summary
- Current Value
- As of today, ALGN annual EBITDA is $851.39M, up +4.23% on
- Historical Performance
- ALGN annual EBITDA is up +5.06% over the past 3 years, up +69.22% over the past 5 years
- All-Time High Comparison
- ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN annual EBITDA is +6.55% above its 3-year low of $799.06M reached on
- Sector Comparison
- ALGN annual EBITDA is higher than 92.64% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $851.39M | +4.2% | +5.1% | +69.2% | +654.8% | |
| Quarterly EBITDA | $261.59M | +21.5% | +58.0% | +7.4% | +1248.3% | |
| TTM EBITDA | $851.41M | +4.2% | +5.1% | +69.2% | +654.8% | |
| Price | $180.03 | +5.7% | -41.3% | -64.4% | +772.6% | |
| PE Ratio | 31.81 | +5.0% | -52.3% | +41.1% | +48.0% | |
| Annual Revenue | $4.03B | +0.9% | +8.0% | +63.2% | +942.3% | |
| Annual EPS | $5.65 | +0.6% | +22.6% | -74.8% | +495.1% | |
| $616.22M | -8.3% | -5.8% | +59.2% | +524.9% | ||
| Annual Net Income | $410.35M | -2.6% | +13.5% | -76.9% | +452.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $851.39M | at high | |
| 5Y | $1.11B | -23.4% | |
| All | $1.11B | -23.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $799.06M | +6.5% | |
| 5Y | $503.14M | N/A | +69.2% |
| All | -$90.85M | +1037.1% |
EBITDA History
FAQ
What is the current annual EBITDA of ALGN?
As of today, ALGN annual EBITDA is $851.39M
What is 1-year change in ALGN annual EBITDA?
ALGN annual EBITDA is up +4.23% year-over-year
What is 3-year change in ALGN annual EBITDA?
ALGN annual EBITDA is up +5.06% over the past 3 years
How far is ALGN annual EBITDA from its all-time high?
ALGN annual EBITDA is currently -23.43% below its historical high of $1.11B set on December 31, 2021
How does ALGN annual EBITDA rank versus sector peers?
ALGN annual EBITDA is higher than 92.64% of companies in Healthcare sector
When is ALGN next annual earnings release?
As of today, the next annual earnings release for ALGN has not been scheduled
Quarterly EBITDA
$261.59M$49.80M+23.52%
Summary
- Current Value
- As of today, ALGN quarterly EBITDA is $261.59M, up +23.52% on
- Historical Performance
- ALGN quarterly EBITDA is up +21.54% year-over-year, up +57.98% over the past 3 years
- All-Time High Comparison
- ALGN quarterly EBITDA is currently -13.18% below its historical high of $301.30M set on
- 3-Year Low Comparison
- ALGN quarterly EBITDA is +57.98% above its 3-year low of $165.58M reached on an earlier date
- Sector Comparison
- ALGN quarterly EBITDA is higher than 92.97% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $261.59M | +23.5% | +21.5% | +58.0% | +7.4% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| TTM EBITDA | $851.41M | +5.8% | +4.2% | +5.1% | +69.2% | |
| Price | $180.03 | +14.1% | +5.7% | -41.3% | -64.4% | |
| PE Ratio | 31.81 | +4.0% | +5.0% | -52.3% | +41.1% | |
| Quarterly Revenue | $1.05B | +5.2% | +5.3% | +16.2% | +25.5% | |
| Quarterly EPS | $1.89 | +141.4% | +35.7% | +251.8% | -5.4% | |
| $159.59M | +2.3% | -9.9% | +28.6% | -25.1% | ||
| Quarterly Net Income | $135.76M | +139.2% | +30.8% | +225.0% | -14.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $261.59M | at high | |
| 3Y | $261.59M | at high | |
| 5Y | $301.30M | -13.2% | |
| All | $301.30M | -13.2% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $174.43M | +50.0% | |
| 3Y | $165.58M | N/A | +58.0% |
| 5Y | $165.58M | +58.0% | |
| All | -$43.85M | +696.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALGN?
As of today, ALGN quarterly EBITDA is $261.59M
What is ALGN quarterly EBITDA most recent change?
ALGN quarterly EBITDA was up +23.52% on December 31, 2025
What is 1-year change in ALGN quarterly EBITDA?
ALGN quarterly EBITDA is up +21.54% year-over-year
How far is ALGN quarterly EBITDA from its all-time high?
ALGN quarterly EBITDA is currently -13.18% below its historical high of $301.30M set on June 30, 2021
How does ALGN quarterly EBITDA rank versus sector peers?
ALGN quarterly EBITDA is higher than 92.97% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
TTM EBITDA
$851.41M$46.37M+5.76%
Summary
- Current Value
- As of today, ALGN TTM EBITDA is $851.41M, up +5.76% on
- Historical Performance
- ALGN TTM EBITDA is up +4.24% year-over-year, up +5.06% over the past 3 years
- All-Time High Comparison
- ALGN TTM EBITDA is currently -23.38% below its historical high of $1.11B set on
- 3-Year Low Comparison
- ALGN TTM EBITDA is +14.79% above its 3-year low of $741.73M reached on
- Sector Comparison
- ALGN TTM EBITDA is higher than 92.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $851.41M | +5.8% | +4.2% | +5.1% | +69.2% | |
| Annual EBITDA | $851.39M | – | +4.2% | +5.1% | +69.2% | |
| Quarterly EBITDA | $261.59M | +23.5% | +21.5% | +58.0% | +7.4% | |
| Price | $180.03 | +14.1% | +5.7% | -41.3% | -64.4% | |
| PE Ratio | 31.81 | +4.0% | +5.0% | -52.3% | +41.1% | |
| TTM Revenue | $4.03B | +1.3% | +0.9% | +8.0% | +63.2% | |
| TTM EPS | $5.66 | +9.7% | +0.6% | +23.0% | -74.8% | |
| $613.97M | -2.8% | -8.6% | -6.1% | +58.6% | ||
| TTM Net Income | $410.35M | +8.4% | -2.6% | +13.5% | -76.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $851.41M | at high | |
| 3Y | $851.41M | at high | |
| 5Y | $1.11B | -23.4% | |
| All | $1.11B | -23.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $793.41M | +7.3% | |
| 3Y | $741.73M | +14.8% | |
| 5Y | $503.14M | N/A | +69.2% |
| All | -$106.47M | +899.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALGN?
As of today, ALGN TTM EBITDA is $851.41M
What is ALGN TTM EBITDA most recent change?
ALGN TTM EBITDA was up +5.76% on December 31, 2025
What is 1-year change in ALGN TTM EBITDA?
ALGN TTM EBITDA is up +4.24% year-over-year
How far is ALGN TTM EBITDA from its all-time high?
ALGN TTM EBITDA is currently -23.38% below its historical high of $1.11B set on December 31, 2021
How does ALGN TTM EBITDA rank versus sector peers?
ALGN TTM EBITDA is higher than 92.06% of companies in Healthcare sector
When is ALGN next earnings release?
The next earnings release for ALGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALGN Official Website www.aligntech.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1097149/000109714926000006/0001097149-26-000006-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1097149/000109714926000006/0001097149-26-000006-index.htm
- ALGN Profile on Yahoo Finance finance.yahoo.com/quote/ALGN
- ALGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/algn